Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Raymundo Garcia"'
Publikováno v:
Anuário do Instituto de Geociências, Vol 7, Pp 7-20 (1983)
Externí odkaz:
https://doaj.org/article/bfb1fe6135134a75b53649b3e631e296
Autor:
Christie M. Ballantyne, Puja Banka, Gustavo Mendez, Raymundo Garcia, Julio Rosenstock, Anthony Rodgers, Geraldine Mendizabal, Yale Mitchel, Alberico L. Catapano
Publikováno v:
Journal of the American College of Cardiology. 81:1553-1564
Autor:
Lauro Sergio Rodrigues da Silva, Gilson da Silva Costa, Raymundo Garcia Cota, Adebaro Alves dos Reis, Juliana Souza da Silva
Publikováno v:
Revista da Associação Brasileira de Pesquisador s Negr s - ABPN. :139-190
Autor:
Yulia Samoilova, Gregory T. Golm, Keith D. Kaufman, Martina Zilli, Yilong Zhang, Chandan Saha, Naim Shehadeh, Samuel S. Engel, Ron S. Newfield, Carmen A. Rosario, Asma Deeb, Lynn W. Scherer, R. Ravi Shankar, Raymond L. H. Lam, Muhammad Yazid Jalaludin, Philip Zeitler, Raymundo Garcia
Publikováno v:
Pediatric diabetesREFERENCES. 23(2)
OBJECTIVE To assess the efficacy and safety of DPP-4 inhibition with sitagliptin in youth with type 2 diabetes (T2D). STUDY DESIGN This was a 54-week, double-blind, randomized, controlled clinical trial evaluating the safety and efficacy of DPP-4 inh
Autor:
Keith D. Kaufman, Asma Deeb, Gregory T. Golm, Philip Zeitler, Martina Zilli, Carmen A. Rosario, Ron S. Newfield, R. Ravi Shankar, Lynn W. Scherer, Raymundo Garcia, Muhammad Yazid Jalaludin, Yulia Samoilova, Samuel S. Engel, Raymond L. H. Lam, Naim Shehadeh, Chandan Saha, Yilong Zhang
Publikováno v:
Pediatric diabetesREFERENCES. 23(2)
Objective To assess the efficacy and safety of sitagliptin in youth with type 2 diabetes (T2D) inadequately controlled with metformin ± insulin. Study design Data were pooled from two 54-week, double-blind, randomized, placebo-controlled studies of
Autor:
Ramamurti Shankar, Keith D. Kaufman, Philip Zeitler, Raymundo Garcia, Yulia Samoilova, Lynn W. Scherer, Ron S. Newfield, Asma Deeb, Zhi Jin Xu, Yilong Zhang, Chandan Saha, Muhammad Yazid Jalaludin, Naim Shehadeh, Samuel S. Engel, Carmen A. Rosario
Publikováno v:
Diabetes. 70
Objectives: To compare the characteristics of younger (Y, 10-14 yrs) vs. older (O, 15-17 yrs) patients (pts) with T2D in global clinical trials of sitagliptin as initial oral therapy (IOT, NCT01485614) or as add-on to metformin therapy (AMT, NCT01472
Autor:
Yulia Samoilova, Samuel S. Engel, Yilong Zhang, Asma Deeb, Philip Zeitler, Muhammad Yazid Jalaludin, Raymundo Garcia, Ron S. Newfield, Zhi Jin Xu, Carmen A. Rosario, Keith D. Kaufman, Lynn W. Scherer, Naim Shehadeh, Ramamurti Shankar, Chandan Saha
Publikováno v:
Diabetes. 70
Objectives: To compare baseline characteristics of 10-17 yr old patients (pts) with T2D from different regions in clinical trials of sitagliptin as initial oral therapy (IOT, NCT01485614) or as add-on to metformin therapy (AMT, NCT01472367, NCT017604
Autor:
Yulia Samoilova, Annpey Pong, Naim Shehadeh, Carmen A. Rosario, Philip Zeitler, Ramamurti Shankar, Muhammad Yazid Jalaludin, Martina Zilli, Chandan Saha, Ron S. Newfield, Keith D. Kaufman, Samuel S. Engel, Raymundo Garcia
Publikováno v:
Diabetes. 68
MK-0431-P083, a 54-week phase III study of the DPP-4 inhibitor sitagliptin as initial oral therapy in patients 10-17 years of age with T2D was initiated in 2012 and completed enrollment in 2018. After informed consent was obtained, patient screening
Autor:
Ron S. Newfield, Ramamurti Shankar, Muhammad Yazid Jalaludin, Kellie Leight, Asma Deeb, Keith D. Kaufman, Yulia Samoilova, Samuel S. Engel, Raymundo Garcia, Chandan Saha, Naim Shehadeh, Philip Zeitler, Veronika P. Pozharskaya, Carmen A. Rosario
Publikováno v:
Diabetes. 68
Approved antihyperglycemic therapies for pediatric patients with T2D are currently limited to metformin (MET) and insulin. SITA is being evaluated in 3 studies in patients 10-17 years of age with T2D: SITA as initial oral therapy, MK-0431 P083; SITA
Publikováno v:
Cirugía y Cirujanos, Vol 92, Iss 6 (2024)
El neumopericardio es una condición inusual que se define por la presencia de gas dentro del saco pericárdico. La perforación gástrica al pericardio es una complicación de la úlcera gástrica con alta mortalidad. En este caso clínico describim
Externí odkaz:
https://doaj.org/article/959bf63c178948d094b00b15ff198395